Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000725166 | SCV000334595 | uncertain significance | not provided | 2015-08-24 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000311992 | SCV000710961 | likely benign | not specified | 2016-08-03 | criteria provided, single submitter | clinical testing | p.Ser8413Ser in exon 97 of TTN: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence. it has been identified in 1/6576 of European ch romosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute. org; dbSNP rs370903846). |
Labcorp Genetics |
RCV001088735 | SCV001009991 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-11-21 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000311992 | SCV006065448 | likely benign | not specified | 2025-04-09 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004543014 | SCV004766493 | likely benign | TTN-related disorder | 2019-11-26 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |